BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Hill-Rom To Host Fiscal First Quarter 2018 Earnings Conference Call And Webcast

  Hill-Rom will host its fiscal first quarter 2018 earnings conference call and webcast on Friday, January 26, 2018, beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET).

  December 20, 2017

   · 

  1 min read
• FDA

  Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients With Completely Resected Melanoma With Lymph Node Involvement or Metastatic Disease

  Bristol-Myers Squibb announced today that the FDA has approved Opdivo (nivolumab) injection for intravenous use for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection.

  December 20, 2017

   · 

  44 min read
• Biotech Bay

  Amarantus Subsidiary MANF Therapeutics Announces Issuance of Japanese Patent Covering Therapeutic Use of MANF in Treatment of Parkinson’s Disease

  The issued patent extends coverage for MANF Therapeutics’ use of MANF in the treatment of Parkinson’s in Japan into 2031.

  December 20, 2017

   · 

  5 min read
• Valeant Completes Sale of Sprout Pharma Subsidiary to Former Shareholders of Sprout Pharma

  Valeant today announced that its affiliate has completed the divestiture of the Sprout to Sprout2, an entity affiliated with certain former shareholders of Sprout, in exchange for a 6% royalty on global sales of ADDYI beginning in May 2019.

  December 20, 2017

   · 

  2 min read
• Business

  Biogen to Report Fourth Quarter and Year-End 2017 Financial Results on January 25, 2018

  Biogen announced it will report fourth quarter and year-end 2017 financial results on Thursday, January 25, 2018, before the financial markets open.

  December 20, 2017

   · 

  1 min read
• Business

  Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update

  As of October 31, 2017, Advaxis had cash, cash equivalents and investments of $70.9 million.

  December 20, 2017

   · 

  7 min read
• BioMidwest

  Life Spine Announces Initial Cases and Multiple Surgeries With the SIMPACT Tri-Fin Sacroiliac Joint Fusion System

  SIMPACT Tri-Fin, which features OSSEO-LOC surface technology, launched November of 2017 and joins Life Spine’s broad portfolio of full procedural solutions.

  December 20, 2017

   · 

  1 min read
• Business

  New Member Appointed to the Board of Directors of Neuralstem

  Dr. Chen was appointed by Tianjin to replace Zhang Zhuo as the director appointee of the Series A Convertible Preferred Stock.

  December 20, 2017

   · 

  3 min read
• Business

  Avivagen Announces Results for Fiscal Year Ending October 31, 2017

  Avivagen today reported its audited financial results for the year ended October 31, 2017 and provided highlights of its fiscal 2018 objectives. Unless otherwise noted, all figures are in Canadian currency.

  December 20, 2017

   · 

  6 min read
• Pharm Country

  Transcat Files Universal Shelf Registration Statement on Form S-3

  The Company has no current plans to issue securities under the registration statement.

  December 20, 2017

   · 

  5 min read